Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphangioleiomyomatosis.

Marilyn K Glassberg1

  • 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Vascular Biology Institute, University of Miami School of Medicine, 1600 North West 10th Avenue, Miami, FL 33136, USA. mglassbe@miami.edu

Clinics in Chest Medicine
|August 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why males scar more: hormonal and chromosomal clues to idiopathic pulmonary fibrosis.

Biology of sex differences·2026
Same author

miR-205-5p drives endothelial dysfunction and senescence in pulmonary fibrosis.

JCI insight·2026
Same author

Aging alters synergistic microRNA networks in exosomes to stimulate repair in lung injury and skin wound healing.

Molecular therapy. Nucleic acids·2026
Same author

Revisiting the INSPIRE trial: antibody profiling reveals high prevalence of occult autoimmunity.

Respiratory research·2026
Same author

Managing Acute Exacerbations in Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in the Intensive Care Unit Setting.

Critical care nursing clinics of North America·2025
Same author

Myocardial pyruvate dehydrogenase kinase 4 drives sex-specific cardiac responses to endotoxemia.

JCI insight·2025

Lymphangioleiomyomatosis (LAM) is a rare disease affecting women, characterized by smooth muscle cell proliferation causing airway obstruction. This review updates current knowledge on this complex pulmonary condition.

Area of Science:

  • Pulmonary Medicine
  • Rare Diseases
  • Cell Biology

Background:

  • Lymphangioleiomyomatosis (LAM) is a rare idiopathic disease primarily affecting women.
  • It involves the proliferation of smooth muscle-like cells in the lungs, leading to airway and vascular obstruction.
  • The natural history and diverse clinical course of pulmonary LAM remain incompletely understood.

Purpose of the Study:

  • To review and update the rapidly expanding knowledge on Lymphangioleiomyomatosis (LAM).
  • To consolidate current understanding of the disease's characteristics, pathology, and clinical presentation.

Main Methods:

  • Comprehensive literature review of existing research on LAM.
  • Synthesis of information from over 400 cited sources.
  • Analysis of pathological and clinical findings reported in the literature.

Related Experiment Videos

Main Results:

  • LAM is defined by abnormal smooth muscle cell proliferation in pulmonary structures.
  • The disease manifests with vascular and airway obstruction and cyst formation.
  • Significant diversity exists in the clinical presentation and progression of LAM.

Conclusions:

  • LAM is a complex pulmonary disease with a variable clinical course.
  • Continued research is essential to fully elucidate the natural history of LAM.
  • This review provides an updated overview of the current state of knowledge on LAM.